Ro 16-6491 hydrochloride

Discontinued Product

Unfortunately Ro 16-6491 hydrochloride (Cat. No. 0376) has been withdrawn from sale for commercial reasons.
Cat.No. 0376 - Ro 16-6491 hydrochloride | CAS No. 94319-79-6
Description: MAO-B inhibitor
Chemical Name: N-(2-Aminoethyl)-4-chlorobenzamide hydrochloride

Biological Activity

MAO-B inhibitor.

Technical Data

M. Wt 235.11
Storage Store at RT
CAS Number 94319-79-6

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

All Tocris products are intended for laboratory research use only.

Preparing Stock Solutions

The following data is based on the product molecular weight 235.11. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 4.25 mL 21.27 mL 42.53 mL
5 mM 0.85 mL 4.25 mL 8.51 mL
10 mM 0.43 mL 2.13 mL 4.25 mL
50 mM 0.09 mL 0.43 mL 0.85 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

Product Datasheets

Certificate of Analysis is currently unavailable
on-line. Please contact Customer Service
Safety Datasheet


References are publications that support the products' biological activity.

Cesura et al (1990) Characterization of the binding of [3H]Ro-41-1049 to the active site of the human monoamine oxidase. Biochem.Pharmacol. 39 216 PMID: 2297358

View Related Products by Product Action

View all Monoamine Oxidase Inhibitors

Keywords: Ro 16-6491 hydrochloride, supplier, Monoamine, Oxidase, Adrenergic, Related, Compounds, Dopaminergic-Related, 5-HT-Related, 5-HT3, Receptors, Monoamine, Oxidase, Tocris Bioscience

Citations for Ro 16-6491 hydrochloride

Citations are publications that use Tocris products.

Currently there are no citations for Ro 16-6491 hydrochloride.

Reviews for Ro 16-6491 hydrochloride

There are currently no reviews for this product. Be the first to review Ro 16-6491 hydrochloride and earn rewards!

Have you used Ro 16-6491 hydrochloride?

Submit a review and receive an Amazon gift card.

$10US/$10CAN/€7/£6 gift card for a review without an image

$25US/$25CAN/€18/£15 gift card for a review with an image

*Offer only valid in the USA / Canada, UK and Europe

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Neurodegeneration Product Guide

A collection of over 275 products for neurodegeneration research, the guide includes research tools for the study of:

  • Alzheimer's disease
  • Parkinson's disease
  • Huntington's disease

Addiction Poster

The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.


Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.


Parkinson's Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.